Zhongzhi Pharmaceutical Holdings Limited (3737.HK)
3737.HK Stock Price Chart
Explore Zhongzhi Pharmaceutical Holdings Limited interactive price chart. Choose custom timeframes to analyze 3737.HK price movements and trends.
3737.HK Company Profile
Discover essential business fundamentals and corporate details for Zhongzhi Pharmaceutical Holdings Limited (3737.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
13 Jul 2015
Employees
2.58K
Website
https://www.zeus.cnCEO
Zhi Tian Lai
Description
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through three segments: Pharmaceutical Manufacturing, Operation of Chain Pharmacies, and Operation of On-Line Pharmacies. It provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brands. The company is also manufacture and sale of food and Chinese herbs; property management; and pharmaceutical drugs, as well as offers detection and testing services. As of December 31, 2021, it operated 398 self-operated chain pharmacies, including 361 medical insurance designated pharmacies located in Zhongshan in the Guangdong Province under the Zeus brand. The company was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited is a subsidiary of Crystal Talent Investment Group Limited.
3737.HK Financial Timeline
Browse a chronological timeline of Zhongzhi Pharmaceutical Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 23 May 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 19 Jun 2025.
Earnings released on 26 Mar 2025
EPS came in at $0.01 , while revenue for the quarter reached $1.20B .
Earnings released on 23 Aug 2024
EPS came in at $0.11 , while revenue for the quarter reached $1.17B .
Dividend declared on 24 May 2024
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Jun 2024.
Earnings released on 23 Mar 2024
EPS came in at $0.04 , while revenue for the quarter reached $1.06B .
Dividend declared on 17 Oct 2023
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 2 Nov 2023.
Earnings released on 24 Aug 2023
EPS came in at $0.17 , while revenue for the quarter reached $1.18B .
Dividend declared on 23 May 2023
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 16 Jun 2023.
Earnings released on 23 Mar 2023
EPS came in at $0.04 , while revenue for the quarter reached $1.12B .
Earnings released on 25 Aug 2022
EPS came in at $0.11 , while revenue for the quarter reached $990.84M .
Earnings released on 31 Dec 2021
EPS came in at -$0.02 , while revenue for the quarter reached $1.05B .
Earnings released on 30 Jun 2021
EPS came in at $0.10 , while revenue for the quarter reached $1.06B .
Earnings released on 31 Dec 2020
EPS came in at $0.10 , while revenue for the quarter reached $1.03B .
Dividend declared on 15 Oct 2020
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 2 Nov 2020.
3737.HK Stock Performance
Access detailed 3737.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.